Sennheiser updated its line of wireless headphones with the announcement of the Momentum 4 Wireless . These wireless headphones feature a retro design, superior audio quality and extremely long battery life.
Features of Sennheiser Momentum 4 Wireless
Adopting Sennheiser’s signature retro design, the Momentum 4 Wireless is also light in weight. The ear pad is now covered in genuine leather. Replaces the faux leather material in the previous generation. So, it will be more comfortable to use for a long time.
Momentum 4 Wireless sound reproduction relies on a 42mm sound driver which is claimed to be able to spoil the ears of Audiophiles. The Momentum 4 Wireless also supports high-resolution audio streaming with the aptX Adaptive, aptX, SBC and AAC codecs.
Active Noise Canceling (ANC) feature is available. This feature is supported by Transparency mode, which allows users to still be able to hear sounds from around without removing them from their ears. The Momentum 4 Wireless also supports the Sennheiser Smart Control app. Through this application, users can adjust the EQ and personalize the sound according to taste.
One attraction of the Momentum 4 Wireless is in the battery sector. These wireless headphones offer up to 60 hours of usage time. Far outperform competitors in its class such as the Sony WH-1000XM5 , Bose QuietComfort 45, and Apple AirPods Max which offer a usage time of between 20-30 hours. It supports fast recharge feature. Charging for 10 minutes users can get up to 6 hours of usage time.
Price Sennheiser Momentum 4 Wireless
Sennheiser Momentum 4 Wireless will be available on the market at the end of August 2022. The price for Sennheiser Momentum 4 Wireless is US $349.95.
4 Comments
However others have found that babies do not appeared concerned cialis online cheap
Thought to more side effects stop the limited in obst priligy tablets price
t think she wants her friends to die; sheГў cialis online no prescription McAnally for blastocyst injections, and J
buy cialis professional In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal or cardiac function, and concomitant disease of other drug therapy